SOURCE: New Life Scientific Inc

January 24, 2006 13:12 ET

New Life Scientific Announces Official Record Date for 1.1 to 1 Stock Split and New Symbol NWLS

FREEHOLD NJ -- (MARKET WIRE) -- January 24, 2006 -- New Life Scientific, Inc (OTC BB: NWLF), today announced the Official Record Date for the 1.1 to 1 forward stock split of the Company's common stock. Each shareholder of record at the close of business on January 25, 2006, will receive 1.1 shares for every share held on the record date. The split will require any existing shareholder to tender their current shares in order to receive their forward split shares. The new symbol on January 25, 2006 will be NWLS.

About New Life Scientific, Inc. (NWLF): New Life Scientific, Inc. was formed with the intent to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cells based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing. New Life Scientific utilizes its strategic geographical positioning in Europe to seek undiscovered, emerging and under-valued biotechnologies in the countries of Eastern Europe, with the further intent of their commercialization.

NWLF recently acquired Novo Life Scientific (Ukraine), the holder of a cooperation agreement with the Institute of Molecular Biology and Genetics of the Ukrainian Academy of Sciences (IMBG). Novo Life Scientific, in conjunction with IMBG, highly regarded for its extensive knowledge and expertise in the fields of molecular cell biology and molecular genetics research, intends to develop and market certain stem cell related products and therapies. New Life Scientific, Inc has also recently acquired PharmaTrials International (PTI), a provider of services in the areas of clinical trials, market research and the regulatory approval of products for pharmaceutical, biotech and medical device companies worldwide.

Safe Harbor Statements under the Private Securities Litigation Reform Act of 1965: Those statements contained herein which are not historical are forward-looking statements, and as such, are subject to risks and uncertainties that could cause actual operating results to materially differ from those contained in the forward-looking statements. Such statements include, but are not limited to, certain delays that are beyond the company's control, with respect to market acceptance of new technologies, or product delays in the testing and evaluation of products, and other risks, as detailed in the company's periodic filings with the Securities and Exchange Commission.

Contact Information